Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 80151-80200 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05657899
The With Or Without Olecranon K-wires Trial
NARecruiting
200 participants
Started: Jan 1, 2023 · Completed: Sep 1, 2029
1 condition2 sponsors2 locations
NCT07035262
Impact of Pre- and Post-operative Serum Metabolome Dynamics in Colorectal Resection Outcomes
N/AActive, not recruiting
400 participants
Started: Jan 1, 2023 · Completed: Sep 1, 2025
1 condition1 sponsor1 location
NCT05123690
Neurofeedback for Post-Traumatic Stress Disorder
NARecruiting
30 participants
Started: Jan 1, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06324682
ConTempoRary Cardiac Stimulation in Clinical practicE: lEft, BivEntriculAr, Right, and conDuction System Pacing
N/ARecruiting
8,400 participants
Started: Jan 1, 2023 · Completed: Dec 31, 2034
25 conditions1 sponsor31 locations
NCT05664464
Glutamate Inhibitors in Glioblastoma
PHASE1/PHASE2Recruiting
120 participants
Started: Jan 1, 2023 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT05115968
Single Cell Sequencing of Tonsillar Tissue in Children With OSA
N/ARecruiting
15 participants
Started: Jan 1, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06221137
Laser Verses Conventional Circumferential Supracrestal Fiberotomy in Orthodontic Extrusion for Crown Lengthening
NARecruiting
20 participants
Started: Jan 1, 2023 · Completed: Sep 30, 2024
3 conditions1 sponsor1 location
NCT05577078
TriBEL Registry: National Belgian Registry of Percutaneous Tricuspid Valve Repair Using a Transcatheter Edge-to-edge Repair Technique
N/ANot yet recruiting
120 participants
Started: Jan 1, 2023 · Completed: Dec 31, 2029
1 condition1 sponsor0 locations
NCT07185646
Mechanistic Study of SPARC-Mediated Regulation of Neutrophil Extracellular Trap Formation in the Brain Metastatic Microenvironment of Breast Cancer
N/AActive, not recruiting
200 participants
Started: Jan 1, 2023 · Completed: Dec 30, 2030
3 conditions1 sponsor1 location
NCT05788744
Implementing ctDNA and Circular DNA in Patients With Localized Pancreatic Cancer
NARecruiting
700 participants
Started: Jan 1, 2023 · Completed: Jan 31, 2030
1 condition4 sponsors5 locations
NCT06903390
Investigation of the Effect of Information on the Empowerment of Cancer Patients Using Question Prompt List: a Mixed Method Study
NAActive, not recruiting
96 participants
Started: Jan 1, 2023 · Completed: Jul 31, 2025
6 conditions1 sponsor1 location
NCT05224063
Probing the Dorsolateral Prefrontal Cortex and Central Executive Network for Improving Neuromodulation in Depression
NARecruiting
50 participants
Started: Jan 1, 2023 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT05843734
Clinical Performance of Glass-hybrid in the Treatment of Class III Restorations
NARecruiting
50 participants
Started: Jan 1, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor2 locations
NCT06383845
Comparison of Erector Spinae Plane Block vs Intravenous Lidocaine for Chronic Pain Post Mastectomy.
NAActive, not recruiting
60 participants
Started: Jan 1, 2023 · Completed: Nov 10, 2025
1 condition1 sponsor1 location
NCT05399446
Multi-Site Eating Disorder Prevention Program for Type 1 Diabetes
NAActive, not recruiting
280 participants
Started: Jan 1, 2023 · Completed: Jan 31, 2027
2 conditions6 sponsors4 locations
NCT05610956
Evaluate the Possible Efficacy and Safety of Empagliflozin in Patient With Ulcerative Colitis
EARLY_PHASE1Recruiting
60 participants
Started: Jan 1, 2023 · Completed: Dec 1, 2026
1 condition1 sponsor1 location
NCT06126263
Adjunctive Clindamycin Versus Linezolid for β-lactam Treated Patients With Invasive Group A Streptococcal Infections
N/AActive, not recruiting
1,000 participants
Started: Jan 1, 2023 · Completed: Jun 30, 2024
6 conditions2 sponsors1 location
NCT06438224
Clinical Utility of ESWT in Restoring Hand Function of Patients With Nerve Injury and Hypertrophic Scars Due to Burns
NARecruiting
120 participants
Started: Jan 1, 2023 · Completed: Aug 20, 2024
3 conditions1 sponsor1 location
NCT06192303
Prospective Study on the Efficacy and Safety of Bronchoalveolar Lavage Combined With Pathogen Metagenomic Sequencing Technology in the Diagnosis of Immune Checkpoint Inhibitor Associated Pneumonia
N/ARecruiting
104 participants
Started: Jan 1, 2023 · Completed: Jan 1, 2026
1 condition1 sponsor1 location
NCT05659420
High Intensity Interval Training in Chronic Heart Failure
NARecruiting
60 participants
Started: Jan 1, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT06275022
A Prospective Study on the Treatment of cLM Based on ICG Imaging
NARecruiting
110 participants
Started: Jan 1, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT06353100
Chronic Pain in the General Population of Chile
N/AActive, not recruiting
2,365 participants
Started: Jan 1, 2023 · Completed: Dec 30, 2024
8 conditions2 sponsors1 location
NCT05121090
Lille Study for Childhood Health Promotion
N/ANot yet recruiting
460 participants
Started: Dec 31, 2022 · Completed: Dec 31, 2026
3 conditions9 sponsors0 locations
NCT05590390
Osteoporosis and Fragility Fractures Among SLE Patients. (FRAIL Trial)
N/AActive, not recruiting
300 participants
Started: Dec 31, 2022 · Completed: Dec 30, 2024
1 condition1 sponsor1 location
NCT05669807
Camrelizumab Combined With Irinotecan or Albumin Paclitaxel for Second-line Treatment of Advanced Gastric Cancer
PHASE2Not yet recruiting
184 participants
Started: Dec 31, 2022 · Completed: Nov 30, 2025
1 condition1 sponsor0 locations
NCT05536128
Evaluating the Efficacy and Safety of Fulvestrant Plus DNA Damage Repair Inhibitors After a CDK4/6 Inhibitor
PHASE2Recruiting
64 participants
Started: Dec 31, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05634590
The Efficacy and Safety of Fruquintinib Plus FOLFIRI/FOLFOX as Second-line Treatment in Patients With RAS-mutant Metastatic Colorectal Cancer
PHASE2Not yet recruiting
68 participants
Started: Dec 31, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04798131
fMRI-based Neurofeedback to Relieve Drug-resistant Auditory Hallucinations
NANot yet recruiting
84 participants
Started: Dec 31, 2022 · Completed: Jul 31, 2026
3 conditions2 sponsors0 locations
NCT06321614
Deep Learning in Classifying Bowel Obstruction Radiographs
N/AActive, not recruiting
4,500 participants
Started: Dec 31, 2022 · Completed: Dec 31, 2024
3 conditions1 sponsor1 location
NCT05665478
Population Pharmacokinetics/Pharmacodynamics of Carbapenems in Febrile Neutropenia Patients
NANot yet recruiting
100 participants
Started: Dec 31, 2022 · Completed: Dec 31, 2025
4 conditions1 sponsor0 locations
NCT04590261
Myeloid Cells in Patients With Covid-19 Pneumonia
NANot yet recruiting
120 participants
Started: Dec 31, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors0 locations
NCT06165718
Study for the Clinical Roadmap and Prognosis of Pulmonary Artery Sarcoma.
N/ARecruiting
120 participants
Started: Dec 31, 2022 · Completed: Jun 30, 2025
1 condition6 sponsors1 location
NCT04794907
Retinal Care Data Repository
N/ANot yet recruiting
1,000 participants
Started: Dec 31, 2022 · Completed: Dec 31, 2030
2 conditions1 sponsor0 locations
NCT05635006
Application of Multitask Deep Learning Model in Grading the Severity of Spinal Facet Joint Degeneration
N/AActive, not recruiting
1,132 participants
Started: Dec 31, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05495802
"Regional Database for Collecting Clinical-biological and Imaging Data Secondary Bone Oncology and Bone Localizations of Hematologic Diseases"
N/ANot yet recruiting
5,000 participants
Started: Dec 31, 2022 · Completed: Dec 31, 2032
1 condition2 sponsors0 locations
NCT05270096
International Leukemia Target Board
N/ARecruiting
600 participants
Started: Dec 31, 2022 · Completed: Jun 1, 2032
2 conditions1 sponsor1 location
NCT05661786
Clinical Outcomes of HBeAg-negative CHB Patients With Indeterminate Phase
N/ARecruiting
4,500 participants
Started: Dec 31, 2022 · Completed: May 31, 2028
1 condition1 sponsor5 locations
NCT05650385
A Study of B1962, a PD-L1/VEGF Bispecific Antibody Fusion Protein, for Advanced Solid Tumors
PHASE1Not yet recruiting
68 participants
Started: Dec 31, 2022 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT05659628
CD19 CAR-T Expressing IL-7 and CCL19 Combined With Anti-PD1 in RR-DLBCL
PHASE1Recruiting
24 participants
Started: Dec 31, 2022 · Completed: Dec 31, 2026
1 condition2 sponsors2 locations
NCT05631041
Effect of Silymarin in Metastatic Colorectal Cancer Patients
PHASE3Recruiting
64 participants
Started: Dec 31, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05395195
Erythropoietin for Neonatal Encephalopathy in LMIC (EMBRACE Trial)
PHASE3Recruiting
504 participants
Started: Dec 31, 2022 · Completed: Dec 1, 2026
3 conditions1 sponsor10 locations
NCT05668767
Surufatinib in Combination of Durvalumab and EP/EC in the Firstly-line Treatment of ES-SCLC
PHASE2Not yet recruiting
20 participants
Started: Dec 31, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor0 locations
NCT05080569
Luteal Phase Support in IUI MOH Treatment Luteal Phase Support in IUI MOH Treatment
PHASE4Not yet recruiting
1,008 participants
Started: Dec 31, 2022 · Completed: Aug 31, 2026
4 conditions1 sponsor0 locations
NCT04827199
Safety and Clinical Performance Study of the ARTUS® Artificial Urinary Sphincter (AUS)
NANot yet recruiting
70 participants
Started: Dec 31, 2022 · Completed: Dec 31, 2034
1 condition3 sponsors3 locations
NCT05652517
Univu-guided Vein of Marshall Ethanol Infusion (Marshall-Merge)
NARecruiting
100 participants
Started: Dec 31, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05562895
A Multicenter Study to Evaluate the Cios Spin and the Ion Endoluminal System for Pulmonary Nodule Biopsy
N/AActive, not recruiting
155 participants
Started: Dec 31, 2022 · Completed: Aug 31, 2025
1 condition1 sponsor6 locations
NCT05609019
A Study Evaluating SYHX2005 in the Treatment of Patients With Advanced Solid Tumors
PHASE1Not yet recruiting
139 participants
Started: Dec 31, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor0 locations
NCT05588115
Rapid, Accurate, Cost-effective Assessment of Blood Biomarkers for Diagnosis of Concussion
N/ANot yet recruiting
225 participants
Started: Dec 31, 2022 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT05666336
Multi-omics Studies on the Efficacy of Telitacicept in Chinese SLE Patients
PHASE4Recruiting
30 participants
Started: Dec 31, 2022 · Completed: Jun 30, 2024
1 condition1 sponsor1 location
NCT05648994
TCR-T Cells for the Treatment NY-ESO-1-positive Advanced Solid Tumors
EARLY_PHASE1Not yet recruiting
30 participants
Started: Dec 31, 2022 · Completed: Mar 31, 2026
1 condition1 sponsor0 locations